- TWD9.71bn
- TWD8.72bn
- TWD9.76bn
- 47
- 58
- 56
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,316 | 8,836 | 8,485 | 8,844 | 9,759 |
Cost of Revenue | |||||
Gross Profit | 531 | 518 | 720 | 813 | 973 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9,283 | 8,772 | 8,242 | 8,511 | 9,294 |
Operating Profit | 32.5 | 64.7 | 242 | 333 | 465 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 164 | 239 | 483 | 612 | 686 |
Provision for Income Taxes | |||||
Net Income After Taxes | 127 | 197 | 404 | 521 | 557 |
Net Income Before Extraordinary Items | |||||
Net Income | 127 | 197 | 404 | 521 | 557 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 127 | 197 | 404 | 521 | 557 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.02 | 1.59 | 3.25 | 4.18 | 4.48 |
Dividends per Share |